Genomic alterations and clinical correlations of Chinese patients with hepatoid adenocarcinoma of the stomach/alpha-fetoprotein gastric cancer.

被引：0
|
作者：
Liu, Tianshu
Chen, Erbao
Xu, Chen
Li, Wei
Li, Qian
Cui, Yuehong
Yu, Yiyi
Shi, Weiwei
Lian, Baofeng
Qu, Yue-Ting
机构：
[1] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China
[2] OrigiMed, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13514
引用
收藏
页数：1
相关论文
共 47 条
  • [41] Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population
    Wang, Liye
    Zhai, Qinglian
    Lu, Qianyi
    Lee, Kaping
    Zheng, Qiufan
    Hong, Ruoxi
    Wang, Shusen
    ANNALS OF MEDICINE, 2021, 53 (01) : 1358 - 1369
  • [42] Clinical validation of an NGS-based assay for detecting multiple genomic alterations in Chinese patients with non-small cell lung cancer
    Ge, H.
    Chen, X.
    Ruan, L.
    Gao, Q.
    Yang, X.
    Shi, W.
    Li, X.
    Zhu, G.
    ANNALS OF ONCOLOGY, 2019, 30 : 3 - 3
  • [43] Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in Chinese population.
    Hong, Ruoxi
    Zhai Qinglian
    Yuan, Zhongyu
    Xia, Wen
    Xu, Fei
    Wang, Shusen
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [44] COMPARISON OF TUMOR-MARKERS CEA, ALPHA-FETOPROTEIN, CA-125, CA-19.9, CA-72.4 AND CA-50 IN PATIENTS WITH ADVANCED GASTRIC-CANCER
    TSAVARIS, N
    GOGOU, L
    TZANINIS, D
    TZIVRAS, M
    KOURAKLIS, G
    KOUTSIOUBAKAZAKOU, P
    KOSMIDIS, P
    ARCHIMANDRITIS, A
    DIAGNOSTIC ONCOLOGY, 1994, 4 (04): : 165 - 169
  • [45] Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: A multicenter retrospective study
    Wang, Wenxian
    Xu, Chunwei
    Chen, Huafei
    Jia, Jinhao
    Wang, Liping
    Feng, Huijing
    Wang, Hong
    Song, Zhengbo
    Yang, Nong
    Zhang, Yongchang
    LUNG CANCER, 2021, 155 : 20 - 27
  • [46] Genomic and clinical characteristics of MET exon14 alterations in a large cohort of Chinese cancer patients revealed distinct features and a novel resistance mechanism for crizotinib
    Cheng, Tianli
    Gu, Zhongping
    Song, Danni
    Liu, Sisi
    Tong, Xiaoling
    Wu, Xue
    Lin, Zhifeng
    Hong, Wei
    JOURNAL OF CANCER, 2021, 12 (03): : 644 - 651
  • [47] Comprehensive analysis of genomic alterations detected by next-generation sequencing-based tissue and circulating tumor DNA assays in Chinese patients with non-small cell lung cancer.
    Yang, Hua
    Zhang, Junjie
    Zhang, Lemeng
    Wen, Xiaoping
    Luo, Yongzhong
    Yao, Dingquan
    Cheng, Tianli
    Cheng, Huanqing
    Wang, Huina
    Lou, Feng
    Guo, Jing
    Liang, Xiayuan
    Cao, Shanbo
    Chen, Jianhua
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345